MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
VOR Vor Biopharma
- 1.320
- +0.200+17.86%
Close Jan 3 16:00 ET
- 1.270
- -0.050-3.78%
Post 20:01 ET
164.40MMarket Cap-0.80P/E (TTM)
1.320High1.170Low1.97MVolume1.180Open1.120Pre Close2.48MTurnover2.54%Turnover RatioLossP/E (Static)124.54MShares3.14052wk High2.25P/B102.55MFloat Cap0.63052wk Low--Dividend TTM77.69MShs Float63.620Historical High--Div YieldTTM13.39%Amplitude0.630Historical Low1.256Avg Price1Lot Size
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Vor Biopharma Stock Forum
Was watching this Friday painting a beautiful chart not sure why I didn't enter but I will likely enter Monday.
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
• Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
...
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback From FDA Regarding Registrational Trial Design
No comment yet